CLINICAL_TRIALS
trial_result
· 2021-09-24
Clinical Trial Update: Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS) [Phase 2]
Summary
Phase 2 clinical trial update for apremilast in moderate to severe palmoplantar pustulosis (PPP) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kristian Reich | Conditions: Palmoplantar Pustulosis | Phase 2 | Status: COMPLETED | Results posted: 2021-09-24